Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PRLD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | David P. Bonita Director, 10% owner | PRLD Prelude Therapeutics Incorporated | Buy | 1.13M | $4.44 | $5.0M Buy | Form 4 ↗ |
| Apr 21, 2026 | David P. Bonita Director, 10% owner | PRLD Prelude Therapeutics Incorporated | Buy | 1.69M | $4.44 | $7.5M Buy | Form 4 ↗ |
| Apr 21, 2026 | OrbiMed Genesis GP LLC Director, 10% owner | PRLD Prelude Therapeutics Incorporated | Buy | 1.13M | $4.44 | $5.0M Buy | Form 4 ↗ |
| Apr 21, 2026 | OrbiMed Genesis GP LLC Director, 10% owner | PRLD Prelude Therapeutics Incorporated | Buy | 1.69M | $4.44 | $7.5M Buy | Form 4 ↗ |
| Mar 25, 2025 | Andrew Combs Chief Chemistry Officer | PRLD Prelude Therapeutics Incorporated | Buy | 100,000 | $0.69 | $69.0K Buy | Form 4 ↗ |
| Mar 25, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 675,000 | $0.69 | $465.8K Buy | Form 4 ↗ |
| Mar 21, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 15,000 | $0.73 | $10.9K Buy | Form 4 ↗ |
| Mar 20, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 5,416 | $0.73 | $3,954 Buy | Form 4 ↗ |
| Mar 17, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 9,106 | $0.75 | $6,830 Buy | Form 4 ↗ |
| Mar 14, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 29,999 | $0.75 | $22.5K Buy | Form 4 ↗ |
| Mar 13, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 50,000 | $0.72 | $36.0K Buy | Form 4 ↗ |
| Mar 12, 2025 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 47,500 | $0.71 | $33.7K Buy | Form 4 ↗ |
| Dec 31, 2024 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 5,000 | $1.21 | $6,050 Buy | Form 4 ↗ |
| Dec 30, 2024 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 10,000 | $1.20 | $12.0K Buy | Form 4 ↗ |
| Dec 23, 2024 | Andrew Combs Chief Chemistry Officer | PRLD Prelude Therapeutics Incorporated | Buy | 60,000 | $1.37 | $82.2K Buy | Form 4 ↗ |
| Dec 20, 2024 | Andrew Combs Chief Chemistry Officer | PRLD Prelude Therapeutics Incorporated | Buy | 3,075 | $1.15 | $3,536 Buy | Form 4 ↗ |
| Dec 19, 2024 | Bryant David Lim CLO, Interim CFO, Corp Sec. | PRLD Prelude Therapeutics Incorporated | Buy | 25,000 | $0.91 | $22.8K Buy | Form 4 ↗ |
| Dec 19, 2024 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 6,888 | $0.89 | $6,130 Buy | Form 4 ↗ |
| Dec 18, 2024 | Krishna Vaddi CEO, Director | PRLD Prelude Therapeutics Incorporated | Buy | 100,000 | $0.93 | $93.0K Buy | Form 4 ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:49 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances